{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:57:03Z","timestamp":1762642623685,"version":"3.40.5"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Study on drug resistance and drug resistance mechanism of Group B streptococcus colonized in the birth canal of pregnant women","award":["2019YJ0083"],"award-info":[{"award-number":["2019YJ0083"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>It has been suggested that small intestinal bacterial overgrowth (SIBO) could cause nonalcoholic fatty liver disease (NAFLD), but this association was not examined in children by meta-analysis. This meta-analysis aimed to determine the association between SIBO and NAFLD in children. The electronic databases PubMed, Embase, and Cochrane Library were searched for studies published before April 22, 2021. The outcome was the association between SIBO and NAFLD. Three studies and 205 children were included. All three studies reported the association between SIBO and NAFLD. Children with SIBO were more likely to have NAFLD (odds ratio = 5.27, 95% confidence interval (CI): 1.66\u201316.68, P&lt;0.001; I<jats:sup>2<\/jats:sup> = 63.5%, P<jats:sub>heterogeneity<\/jats:sub> = 0.065). When directly pooling the reported relative risks (RR) from two studies, children with NAFLD had an over 2-fold increased relative risk of developing SIBO (RR = 2.17, 05%CI: 1.66\u20132.82, P&lt;0.001; I<jats:sup>2<\/jats:sup> = 0.0%, P<jats:sub>heterogeneity<\/jats:sub> = 0.837). This meta-analysis reports a possible association between SIBO and NAFLD in children.<\/jats:p>","DOI":"10.1371\/journal.pone.0260479","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T19:09:47Z","timestamp":1638472187000},"page":"e0260479","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis"],"prefix":"10.1371","volume":"16","author":[{"given":"Linghan","family":"Kuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9840-8295","authenticated-orcid":true,"given":"Yongmei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"issue":"22","key":"pone.0260479.ref001","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"ME Rinella","year":"2015","journal-title":"Jama"},{"issue":"7","key":"pone.0260479.ref002","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"N Chalasani","year":"2012","journal-title":"Gastroenterology"},{"issue":"10113","key":"pone.0260479.ref003","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults","volume":"390","author":"Collaboration NCDRF","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"pone.0260479.ref004","doi-asserted-by":"crossref","first-page":"e0140908","DOI":"10.1371\/journal.pone.0140908","article-title":"The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis","volume":"10","author":"EL Anderson","year":"2015","journal-title":"PloS one"},{"issue":"9","key":"pone.0260479.ref005","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1080\/00365520801947074","article-title":"Small intestinal bacterial overgrowth","volume":"43","author":"SV Rana","year":"2008","journal-title":"Scandinavian journal of gastroenterology"},{"issue":"2","key":"pone.0260479.ref006","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11894-015-0482-9","article-title":"How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach","volume":"18","author":"A Rezaie","year":"2016","journal-title":"Current gastroenterology reports"},{"issue":"24","key":"pone.0260479.ref007","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3748\/wjg.v16.i24.2978","article-title":"Small intestinal bacterial overgrowth syndrome","volume":"16","author":"J Bures","year":"2010","journal-title":"World journal of gastroenterology"},{"issue":"2","key":"pone.0260479.ref008","doi-asserted-by":"crossref","first-page":"159","DOI":"10.15403\/jgld.2014.1121.252.iwg","article-title":"Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease.","volume":"25","author":"A Fialho","year":"2016","journal-title":"Journal of gastrointestinal and liver diseases: JGLD"},{"issue":"5","key":"pone.0260479.ref009","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12664-017-0797-6","article-title":"Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture.","volume":"36","author":"UC Ghoshal","year":"2017","journal-title":"Indian journal of gastroenterology: official journal of the Indian Society of Gastroenterology."},{"issue":"Suppl 1","key":"pone.0260479.ref010","first-page":"13","article-title":"The value of hydrogen an methane breath test to detect SIBO on exploring the role of intestinal flora in the incidence of nonalcoholic fatty liverdisease","volume":"17","author":"Q Lei","year":"2016","journal-title":"J Dig Dis"},{"issue":"6","key":"pone.0260479.ref011","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"L Miele","year":"2009","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"pone.0260479.ref012","doi-asserted-by":"crossref","first-page":"S988","DOI":"10.14309\/00000434-201510001-02380","article-title":"Characterization of patients undergoing breath testing for small intestinal bacterial overgrowth (SIBO)","volume":"110","author":"BSJ Mohamad","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"pone.0260479.ref013","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jceh.2015.07.265","article-title":"Prevalence of small intestinal bacterial overgrowth (SIBO) and insulin resistance in both obese and non obese non-alcoholic fatty liver disease (NAFLD) patients","volume":"5","author":"SNB Nongthombam","year":"2015","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"pone.0260479.ref014","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2036.2005.02562.x","article-title":"Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis","volume":"22","author":"A Sajjad","year":"2005","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"5","key":"pone.0260479.ref015","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s10620-010-1447-3","article-title":"Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8","volume":"56","author":"AA Shanab","year":"2011","journal-title":"Digestive diseases and sciences"},{"issue":"7","key":"pone.0260479.ref016","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s10620-012-2112-9","article-title":"Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)","volume":"57","author":"V Volynets","year":"2012","journal-title":"Digestive diseases and sciences"},{"issue":"2","key":"pone.0260479.ref017","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis","volume":"48","author":"AJ Wigg","year":"2001","journal-title":"Gut"},{"issue":"9","key":"pone.0260479.ref018","doi-asserted-by":"crossref","DOI":"10.3390\/nu9091013","article-title":"Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment","volume":"9","author":"A Brandt","year":"2017","journal-title":"Nutrients"},{"issue":"3","key":"pone.0260479.ref019","doi-asserted-by":"crossref","first-page":"E740","DOI":"10.1152\/ajpendo.00302.2006","article-title":"Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes","volume":"292","author":"SJ Creely","year":"2007","journal-title":"American journal of physiology Endocrinology and metabolism"},{"issue":"7","key":"pone.0260479.ref020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071431","article-title":"LPS-Induced Low-Grade Inflammation Increases Hypothalamic JNK Expression and Causes Central Insulin Resistance Irrespective of Body Weight Changes","volume":"18","author":"R Rorato","year":"2017","journal-title":"International journal of molecular sciences"},{"key":"pone.0260479.ref021","doi-asserted-by":"crossref","first-page":"9547613","DOI":"10.1155\/2018\/9547613","article-title":"Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease","volume":"2018","author":"M Masarone","year":"2018","journal-title":"Oxidative medicine and cellular longevity"},{"issue":"2","key":"pone.0260479.ref022","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"L Zhu","year":"2013","journal-title":"Hepatology"},{"issue":"33","key":"pone.0260479.ref023","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1073\/pnas.0601056103","article-title":"Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice","volume":"103","author":"ME Dumas","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"pone.0260479.ref024","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"B Schnabl","year":"2014","journal-title":"Gastroenterology"},{"issue":"5","key":"pone.0260479.ref025","first-page":"1399","article-title":"Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation","volume":"22","author":"AL Buchman","year":"1995","journal-title":"Hepatology"},{"issue":"11","key":"pone.0260479.ref026","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3748\/wjg.v13.i11.1732","article-title":"Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in rats","volume":"13","author":"X Jin","year":"2007","journal-title":"World journal of gastroenterology"},{"issue":"5","key":"pone.0260479.ref027","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/MEG.0000000000001541","article-title":"Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"32","author":"K Wijarnpreecha","year":"2020","journal-title":"European journal of gastroenterology & hepatology"},{"issue":"2","key":"pone.0260479.ref028","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1586\/17474124.2016.1110017","article-title":"Diagnosis and treatment of small intestinal bacterial overgrowth","volume":"10","author":"FR Ponziani","year":"2016","journal-title":"Expert review of gastroenterology & hepatology"},{"issue":"1","key":"pone.0260479.ref029","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5152\/tao.2019.4058","article-title":"A Guide for Systematic Reviews: PRISMA","volume":"57","author":"AA Selcuk","year":"2019","journal-title":"Turkish archives of otorhinolaryngology"},{"key":"pone.0260479.ref030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"CK Lo","year":"2014","journal-title":"BMC medical research methodology"},{"key":"pone.0260479.ref031","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019).","author":"JPT Higgins","year":"2019"},{"issue":"5","key":"pone.0260479.ref032","doi-asserted-by":"crossref","DOI":"10.3390\/nu9050485","article-title":"Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways\/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations","volume":"9","author":"J Troisi","year":"2017","journal-title":"Nutrients"},{"issue":"11","key":"pone.0260479.ref033","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1515\/jpem-2017-0252","article-title":"The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents.","volume":"30","author":"O Belei","year":"2017","journal-title":"Journal of pediatric endocrinology & metabolism: JPEM"},{"issue":"4","key":"pone.0260479.ref034","doi-asserted-by":"crossref","first-page":"266","DOI":"10.22141\/2308-2097.53.4.2019.182406","article-title":"Association of small intestinal bacterial overgrowth and non-alcoholic fatty liver disease in children","volume":"53","author":"YM Stepanov","year":"2019","journal-title":"Gastroenterolog\u00eca"},{"issue":"12","key":"pone.0260479.ref035","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.3390\/nu6125583","article-title":"The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease","volume":"6","author":"SM Ferolla","year":"2014","journal-title":"Nutrients"},{"issue":"1","key":"pone.0260479.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/ceh.2019.83151","article-title":"Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease","volume":"5","author":"M Augustyn","year":"2019","journal-title":"Clinical and experimental hepatology"},{"issue":"1","key":"pone.0260479.ref037","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jgh.13058","article-title":"Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease","volume":"31","author":"S Kapil","year":"2016","journal-title":"Journal of gastroenterology and hepatology"},{"key":"pone.0260479.ref038","first-page":"52","article-title":"The role of Toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation","volume":"60","author":"M Majewska","year":"2006","journal-title":"Postepy higieny i medycyny doswiadczalnej"},{"issue":"29","key":"pone.0260479.ref039","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.2174\/13816128113199990344","article-title":"Pathophysiology of NASH: perspectives for a targeted treatment","volume":"19","author":"F Marra","year":"2013","journal-title":"Current pharmaceutical design"},{"issue":"2","key":"pone.0260479.ref040","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"F Marra","year":"2018","journal-title":"Journal of hepatology"},{"key":"pone.0260479.ref041","first-page":"204","article-title":"Obesity-induced inflammation and insulin resistance","volume":"5","author":"T. Ota","year":"2014","journal-title":"Frontiers in endocrinology"},{"issue":"1","key":"pone.0260479.ref042","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI88880","article-title":"Skeletal muscle inflammation and insulin resistance in obesity","volume":"127","author":"H Wu","year":"2017","journal-title":"The Journal of clinical investigation"},{"issue":"3","key":"pone.0260479.ref043","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00394-017-1524-x","article-title":"Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis","volume":"57","author":"F de Faria Ghetti","year":"2018","journal-title":"European journal of nutrition"},{"issue":"1\u20132","key":"pone.0260479.ref044","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/pr.2014.157","article-title":"Gut microbiome and nonalcoholic fatty liver diseases","volume":"77","author":"L Zhu","year":"2015","journal-title":"Pediatric research"},{"key":"pone.0260479.ref045","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3389\/fmicb.2016.00979","article-title":"Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut","volume":"7","author":"A Riviere","year":"2016","journal-title":"Frontiers in microbiology"},{"issue":"5","key":"pone.0260479.ref046","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1572-0241.1999.01016.x","article-title":"Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome","volume":"94","author":"Y Bouhnik","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"36","key":"pone.0260479.ref047","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.3748\/wjg.v23.i36.6571","article-title":"Nonalcoholic fatty liver disease: Evolving paradigms","volume":"23","author":"A Lonardo","year":"2017","journal-title":"World journal of gastroenterology"},{"issue":"8","key":"pone.0260479.ref048","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).","volume":"65","author":"E Buzzetti","year":"2016","journal-title":"Metabolism: clinical and experimental"},{"issue":"5","key":"pone.0260479.ref049","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"L Gatta","year":"2017","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"4","key":"pone.0260479.ref050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","article-title":"Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence","volume":"51","author":"C Zhong","year":"2017","journal-title":"J Clin Gastroenterol."},{"issue":"5","key":"pone.0260479.ref051","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1159\/000495830","article-title":"Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression","volume":"51","author":"Y Zhou","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"pone.0260479.ref052","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3389\/fendo.2019.00611","article-title":"Gut Dysfunction and Non-alcoholic Fatty Liver Disease","volume":"10","author":"F Grabherr","year":"2019","journal-title":"Frontiers in endocrinology"},{"issue":"5","key":"pone.0260479.ref053","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"H Tilg","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"pone.0260479.ref054","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40264-016-0493-y","article-title":"Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases","volume":"40","author":"C Ferrajolo","year":"2017","journal-title":"Drug Saf"},{"key":"pone.0260479.ref055","first-page":"156389","article-title":"A challenge for diagnosing acute liver injury with concomitant\/sequential exposure to multiple drugs: can causality assessment scales be utilized to identify the offending drug?","volume":"2014","author":"R Lim","year":"2014","journal-title":"Case Rep Pediatr"},{"issue":"7","key":"pone.0260479.ref056","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/jac\/dkr159","article-title":"Hepatic safety of antibiotics used in primary care","volume":"66","author":"RJ Andrade","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"pone.0260479.ref057","unstructured":"Clinical Course and Diagnosis of Drug Induced Liver Disease. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD)2012."},{"issue":"3","key":"pone.0260479.ref058","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5056\/jnm.2011.17.3.312","article-title":"How to interpret hydrogen breath tests","volume":"17","author":"UC Ghoshal","year":"2011","journal-title":"Journal of neurogastroenterology and motility"},{"issue":"3","key":"pone.0260479.ref059","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/gut.2005.075127","article-title":"Use and abuse of hydrogen breath tests","volume":"55","author":"M Simren","year":"2006","journal-title":"Gut"},{"issue":"1","key":"pone.0260479.ref060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cld.685","article-title":"Risk factors for progression of and treatment options for NAFLD in children","volume":"11","author":"P Hartmann","year":"2018","journal-title":"Clinical liver disease"},{"issue":"6","key":"pone.0260479.ref061","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060947","article-title":"A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence","volume":"17","author":"JL Temple","year":"2016","journal-title":"International journal of molecular sciences"},{"issue":"2","key":"pone.0260479.ref062","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).","volume":"64","author":"MB Vos","year":"2017","journal-title":"Journal of pediatric gastroenterology and nutrition"},{"issue":"3","key":"pone.0260479.ref063","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-4078","article-title":"Epidemic Childhood Obesity: Not Yet the End of the Beginning","volume":"141","author":"DS Ludwig","year":"2018","journal-title":"Pediatrics"},{"issue":"5","key":"pone.0260479.ref064","first-page":"582","article-title":"Probiotics, prebiotics & synbiotics in small intestinal bacterial overgrowth: opening up a new therapeutic horizon!","volume":"140","author":"WC Chen","year":"2014","journal-title":"Indian J Med Res"},{"key":"pone.0260479.ref065","first-page":"4181748","article-title":"Effect of Combined Live Probiotics Alleviating the Gastrointestinal Symptoms of Functional Bowel Disorders","volume":"2020","author":"J Shi","year":"2020","journal-title":"Gastroenterology research and practice"},{"issue":"5","key":"pone.0260479.ref066","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/2040622313496126","article-title":"Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance","volume":"4","author":"AH Sachdev","year":"2013","journal-title":"Ther Adv Chronic Dis"},{"issue":"1","key":"pone.0260479.ref067","first-page":"6","article-title":"Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time","volume":"25","author":"UC Ghoshal","year":"2006","journal-title":"Indian journal of gastroenterology: official journal of the Indian Society of Gastroenterology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T19:10:54Z","timestamp":1638472254000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260479"}},"subtitle":[],"editor":[{"given":"Nikhil","family":"Pai","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":67,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0260479","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2021,12,2]]}}}